Staff Members - Benha University
Proenkephalin A119-159 as a biomarker of acute kidney injury in ICU patients with sepesis
• 2022
Publication Information
Authors
Mohamed E. Ibrahim, Mohamed Ibrahim Mohamed Badr, Dalia Mohamed Abd El-Hassib and Ahmed Wageh Mahdey
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
ABSTRACT
Background: Sepsis is a potentially fatal illness caused by an unbalanced host response to infection. Sepsis is becoming more common, indicating that it is a main cause of severe disease and fatality globally. Patients with sepsis commonly
have simultaneous acute kidney injury (AKI), with rates ranging from 5 to 20% among hospital admissions and increasing to 35-50% among the seriously sick. Because proenkephalin is not bound to proteins in plasma and is only filtrated in the glomerulus, it is a promising biomarker for renal impairment in critically sick patients. Objective: The
aim of the current study was to assess Proenkephalin A119-159 (penKid) as a biomarker for sepsis related AKI in ICU patients. Patients and methods: A case control study was conducted at intensive care unit (ICU) department, Benha Faculty of Medicine on a total of 80 subjects which were divided into 50 septic AKI cases and 30 matched age and sex controls. Subjects met two or more SIRS-criteria and their estimated glomerular filtration rate (eGFR) was determined by the formula derived from the Modification of Diet in Renal Disease (MDRD) Study and the Proenkephalin A119-159 (penkid) was measured by ELISA. Results: The current study demonstrated that, septic AKI cases demonstrated
significant increase in penkid compared to control group(p
Background: Sepsis is a potentially fatal illness caused by an unbalanced host response to infection. Sepsis is becoming more common, indicating that it is a main cause of severe disease and fatality globally. Patients with sepsis commonly
have simultaneous acute kidney injury (AKI), with rates ranging from 5 to 20% among hospital admissions and increasing to 35-50% among the seriously sick. Because proenkephalin is not bound to proteins in plasma and is only filtrated in the glomerulus, it is a promising biomarker for renal impairment in critically sick patients. Objective: The
aim of the current study was to assess Proenkephalin A119-159 (penKid) as a biomarker for sepsis related AKI in ICU patients. Patients and methods: A case control study was conducted at intensive care unit (ICU) department, Benha Faculty of Medicine on a total of 80 subjects which were divided into 50 septic AKI cases and 30 matched age and sex controls. Subjects met two or more SIRS-criteria and their estimated glomerular filtration rate (eGFR) was determined by the formula derived from the Modification of Diet in Renal Disease (MDRD) Study and the Proenkephalin A119-159 (penkid) was measured by ELISA. Results: The current study demonstrated that, septic AKI cases demonstrated
significant increase in penkid compared to control group(p